ada standards of care 2025 glp-1 receptor agonists recommendations 🚨 The 2026 and NICE guidelines now agree on something that would have been unthinkable five years ago. and SGLT2 inhibitors belong at the front type 2 ADA Updates Diabetes Treatment Guidelines

Turmeric Extract - Supports Antioxidant Activity*

The gut microbiome influences many aspects of metabolic health including digestive signaling, short-chain fatty acid production, immune communication, and gut barrier integrity

Partly through these actions, GLP-1 receptor agonism was shown to reduce cardiovascular disease (CVD) in people with T2D with previous CVD or at high-risk thereof

Otolaryngologist patients with medullary thyroid cancer should not be taking GLP-1 medications at this time due to the risk.

Research on the experimental drug petrelintide suggests it is much less likely to cause nausea and vomiting than GLP-1 drugs, but the pace of weight loss is more moderate.